Gastroenterology Research and Practice / 2013 / Article / Tab 1

Research Article

Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo

Table 1

Primer sequences of NET-1, caspase 3, caspase 8, caspase 9, and GAPDH.

PrimerSequenceProduct (bp)

NET-1-F′5′-GTGGCTTCACCAACTATACG-3′191
NET-1-R′5′-GACTGCATTAGTTCGGATGT-3′
Caspase-3-F′5′-AGAACTGGACTGTGGCATTGAG-3′191
Caspase-3-R′5′-GCTTGTCGGCATACTGTTTCAG-3′
Caspase-8-F′5′-CATCCAGTCACTTTGCCAGA-3′128
Caspase-8-R′5′-GCATCTGTTTCCCCATGTTT-3′
Caspase-9-F′5′-TTCCCAGGTTTTGTTTCCTG-3′143
Caspase-9-R′5′-CCTTTCACCGAAACAGCATT-3′
GAPDH-F′5′-TGATGACATCAAGAAGGTGGTGAAG-3′240
GAPDH-R′5′-TCCTTGGAGGCCATGTGGGCCAT-3′

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.